CHB 111

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCHB 111

Drug Alias NameHepaVaxx BCHB-111

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHepatitis B

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesVirexx Medical Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesVirexx Medical Corp

Active IndicationsN/A

Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A